Skip to content

Clinical trials

Completed Phase 1/2 Retinitis Pigmentosa trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Retinitis Pigmentosa Phase: Phase 1/2 Status: Completed Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20081
20111
20142
20152
20182
20193
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie1
Acibadem University1
Allergan1
Dompé Farmaceutici S.p.A1
Kiora Pharmaceuticals, Inc.1
Nanoscope Therapeutics Inc.1
National Center for Complementary and Integrative Health (NCCIH)1
National Eye Institute (NEI)1
Novartis Pharmaceuticals1
PT. Prodia Stem Cell Indonesia1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Retinitis Pigmentosa13
Choroideremia2
Retinal Diseases2
Cone-Rod Dystrophies1
Eye Abnormalities1
Eye Diseases1
Eye Diseases, Hereditary1
Macular Edema1
Retinal Degeneration1
Usher Syndromes1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.